LakeShore Biopharma Co., Ltd (LSB)
NASDAQ: LSB · IEX Real-Time Price · USD
0.490
-0.010 (-2.02%)
At close: Jul 19, 2024, 4:00 PM
0.410
-0.080 (-16.31%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
LakeShore Biopharma Market Cap
LakeShore Biopharma has a market cap or net worth of $92.26 million as of July 22, 2024. Its market cap has decreased by -27.12% in one year.
Market Cap
92.26M
Enterprise Value
138.41M
1-Year Change
-27.12%
Ranking
Category
Stock Price
Market Cap Chart
Since June 9, 2021, LakeShore Biopharma's market cap has decreased from $257.50M to $92.26M, a decrease of -64.17%. That is a compound annual growth rate of -28.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 45.60M | -4.20% |
| Dec 29, 2023 | 47.60M | -81.56% |
| Dec 30, 2022 | 258.10M | 3.12% |
| Dec 31, 2021 | 250.30M | -2.80% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anixa Biosciences | 94.10M |
| Aclaris Therapeutics | 94.07M |
| 111, Inc. | 93.71M |
| Assembly Biosciences | 93.29M |
| Asensus Surgical | 92.55M |
| Eupraxia Pharmaceuticals | 91.19M |
| Cellectar Biosciences | 90.34M |
| Eton Pharmaceuticals | 89.92M |